Results 1 to 10 of about 12,785 (220)

Identifying Diagnostic Thresholds for the Assessment of Cerebrovascular Reserve Impairment in Moyamoya Disease: CO₂-Triggered BOLD-MRI and [¹⁵O]water-PET with Acetazolamide Challenge [PDF]

Brain Sciences
Background: Assessment of cerebrovascular reserve capacity (CVRC) is central to treatment planning in adult Moyamoya disease. [15O]-water-PET with acetazolamide challenge (PET-ACZ) serves as the reference standard but is resource-intensive and not ...
Patrick Haas, Lucas Moritz Wiggenhauser, Johannes Spang, Leonie Zerweck, Christian Volz, Marcos Tatagiba, Nadia Khan, Philipp T. Meyer, Till-Karsten Hauser, Constantin Roder   +9 more
doaj   +2 more sources

A case of anterior cranial fossa dural arteriovenous fistula concomitant with moyamoya disease [PDF]

Radiology Case Reports
Moyamoya disease is rarely complicated by other cerebrovascular diseases. A man in his 60s presented with subcortical hemorrhage in the left frontal lobe with an anterior cranial fossa dural arteriovenous fistula (dAVF) and concomitant asymptomatic ...
Junki Youda, MD, Tatsuya Shimizu, MD, Ryousuke Shintoku, MD, Masanori Aihara, MD, Masahiko Tosaka, MD, Soichi Oya, MD   +5 more
doaj   +2 more sources

Early Post-operative CT-Angiography Imaging After EC-IC Bypass Surgery in Moyamoya Patients

Frontiers in Neurology, 2021
Objective: To evaluate the clinical value of early post-operative computed tomographic angiography (CTA) after direct extracranial-intracranial (EC-IC) bypass surgery in moyamoya patients.Methods: A retrospective analysis of all adult moyamoya patients ...
Helene Hurth, Helene Hurth, Till-Karsten Hauser, Patrick Haas, Patrick Haas, Sophie Wang, Sophie Wang, Annerose Mengel, Annerose Mengel, Marcos Tatagiba, Marcos Tatagiba, Marcos Tatagiba, Ulrike Ernemann, Ulrike Ernemann, Nadia Khan, Nadia Khan, Nadia Khan, Constantin Roder, Constantin Roder, Constantin Roder   +19 more
doaj   +1 more source

Increased Autoimmunity in Individuals With Down Syndrome and Moyamoya Disease

Frontiers in Neurology, 2021
Objective: To determine if elevated rates of autoimmune disease are present in children with both Down syndrome and moyamoya disease given the high rates of autoimmune disease reported in both conditions and unknown etiology of angiopathy in this ...
Jonathan D. Santoro, Jonathan D. Santoro, Sarah Lee, Anthony C. Wang, Eugenia Ho, Eugenia Ho, Deepti Nagesh, Deepti Nagesh, Mellad Khoshnood, Runi Tanna, Ramon A. Durazo-Arvizu, Melanie A. Manning, Melanie A. Manning, Brian G. Skotko, Brian G. Skotko, Gary K. Steinberg, Michael S. Rafii, Michael S. Rafii   +17 more
doaj   +1 more source

Clinical value of the systemic immune-inflammation index in moyamoya disease

Frontiers in Neurology, 2023
BackgroundMoyamoya disease (MMD) is a rare cerebrovascular disorder with unknown etiology. The underlying pathophysiological mechanism of moyamoya disease remains to be elucidated, but recent studies have increasingly highlighted that abnormal immune ...
Erheng Liu, Erheng Liu, Chengyuan Liu, Chengyuan Liu, Lide Jin, Hu Zhou, Xueyi Tan, Xueyi Tan, Guibo Zhang, Guibo Zhang, Weihua Tao, Xiang Gao, Heng Zhao, Chao Luo, Xuehua Li, Shuaifeng Yang   +15 more
doaj   +1 more source

Predictors of preoperative cognitive dysfunction in adults with Moyamoya disease: a preliminary research

BMC Neurology, 2022
Objective To explore potential risk factors of preoperative cognitive dysfunction in adult patients with moyamoya disease (MMD) and discuss significance of moyamoya vessels.
Jian Sun, Zhiyong Shi, Lebao Yu, Yujie Wen, Dong Zhang   +4 more
doaj   +1 more source

Diagnostic Criteria for Moyamoya Disease - 2021 Revised Version

Neurologia Medico-Chirurgica, 2022
In this report, we, the Research Committee on Moyamoya Disease (Spontaneous Occlusion of the circle of Willis), describe in detail the changes in the new “Diagnostic Criteria 2021” for moyamoya disease and its scientific basis to make it widely known to ...
Satoshi KURODA, Miki FUJIMURA, Jun TAKAHASHI, Hiroharu KATAOKA, Kuniaki OGASAWARA, Toru IWAMA, Teiji TOMINAGA, Susumu MIYAMOTO, The Research Committee on Moyamoya Disease (Spontaneous Occlusion of Circle of Willis) of the Ministry of Health, Labor, and Welfare, Japan   +8 more
doaj   +1 more source

Whole exome sequencing identifies MRVI1 as a susceptibility gene for moyamoya syndrome in neurofibromatosis type 1. [PDF]

PLoS ONE, 2018
BACKGROUND AND PURPOSE:Moyamoya angiopathy is a progressive cerebral vasculopathy. The p.R4810K substitution in RNF213 has previously been linked to moyamoya disease in Asian populations.
Claudia Santoro, Teresa Giugliano, Markus Kraemer, Annalaura Torella, Jan Claudius Schwitalla, Mario Cirillo, Daniela Melis, Peter Berlit, Vincenzo Nigro, Silverio Perrotta, Giulio Piluso   +10 more
doaj   +1 more source

Abstract Number ‐ 281: Clinical and Epidemiological Characteristics of Moyamoya Disease Presenting with Concomitant Autoimmune Conditions

Stroke: Vascular and Interventional Neurology, 2023
Introduction Moyamoya disease was first described in the 1950’s. After over six decades, however, the underlying etiology of Moyamoya still remains unknown.
Nolan Brown, Rohin Singh, Daniel Harrison, Megan Bauman, Andreas Seas, Shane Shahrestani, Julian Gendreau, Oren Gottfried   +7 more
doaj   +1 more source

Enfermedad de Moyamoya

Revista del Hospital Italiano de Buenos Aires, 2022
Paciente de 54 años con antecedentes de ictus se somete a una angiografía que muestra una AC derecha de calibre fino con oclusión de la arteria oftálmica y oclusión del TCI.
Nicolas A. Gemelli
doaj   +1 more source